Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
3410 | 1915 | 35.8 | 85% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
128 | 23028 | EPENDYMOMA//MEDULLOBLASTOMA//GLIOBLASTOMA |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | PSEUDOPROGRESSION | Author keyword | 38 | 60% | 2% | 42 |
2 | GLIOMA GRADING | Author keyword | 21 | 85% | 1% | 11 |
3 | MACDONALD CRITERIA | Author keyword | 12 | 86% | 0% | 6 |
4 | PERFUSION MRI | Author keyword | 11 | 25% | 2% | 40 |
5 | PSEUDORESPONSE | Author keyword | 11 | 78% | 0% | 7 |
6 | PERFUSION MR IMAGING | Author keyword | 10 | 61% | 1% | 11 |
7 | MR PERFUSION | Author keyword | 10 | 37% | 1% | 22 |
8 | RADIATION NECROSIS | Author keyword | 10 | 20% | 2% | 42 |
9 | DSC MRI | Author keyword | 9 | 41% | 1% | 17 |
10 | VOLUME TRANSFER CONSTANT | Author keyword | 9 | 83% | 0% | 5 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | PSEUDOPROGRESSION | 38 | 60% | 2% | 42 | Search PSEUDOPROGRESSION | Search PSEUDOPROGRESSION |
2 | GLIOMA GRADING | 21 | 85% | 1% | 11 | Search GLIOMA+GRADING | Search GLIOMA+GRADING |
3 | MACDONALD CRITERIA | 12 | 86% | 0% | 6 | Search MACDONALD+CRITERIA | Search MACDONALD+CRITERIA |
4 | PERFUSION MRI | 11 | 25% | 2% | 40 | Search PERFUSION+MRI | Search PERFUSION+MRI |
5 | PSEUDORESPONSE | 11 | 78% | 0% | 7 | Search PSEUDORESPONSE | Search PSEUDORESPONSE |
6 | PERFUSION MR IMAGING | 10 | 61% | 1% | 11 | Search PERFUSION+MR+IMAGING | Search PERFUSION+MR+IMAGING |
7 | MR PERFUSION | 10 | 37% | 1% | 22 | Search MR+PERFUSION | Search MR+PERFUSION |
8 | RADIATION NECROSIS | 10 | 20% | 2% | 42 | Search RADIATION+NECROSIS | Search RADIATION+NECROSIS |
9 | DSC MRI | 9 | 41% | 1% | 17 | Search DSC+MRI | Search DSC+MRI |
10 | VOLUME TRANSFER CONSTANT | 9 | 83% | 0% | 5 | Search VOLUME+TRANSFER+CONSTANT | Search VOLUME+TRANSFER+CONSTANT |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | CEREBRAL BLOOD VOLUME | 113 | 35% | 14% | 267 |
2 | INTRACRANIAL MASS LESIONS | 102 | 66% | 5% | 94 |
3 | SOLITARY METASTASES | 78 | 83% | 2% | 44 |
4 | BLOOD VOLUME MAPS | 57 | 69% | 3% | 49 |
5 | HIGH GRADE GLIOMAS | 52 | 19% | 13% | 245 |
6 | SHORT ECHO TIME | 49 | 66% | 2% | 45 |
7 | CEREBRAL GLIOMAS | 47 | 32% | 6% | 121 |
8 | CONTRAST ENHANCED MR | 39 | 38% | 4% | 82 |
9 | PSEUDO PROGRESSION | 35 | 86% | 1% | 18 |
10 | IMAGE GUIDED HISTOPATHOLOGY | 34 | 93% | 1% | 13 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Pseudoprogression and Pseudoresponse: Imaging Challenges in the Assessment of Posttreatment Glioma | 2011 | 55 | 32 | 69% |
Advances in MRI Assessment of Gliomas and Response to Anti-VEGF Therapy | 2011 | 39 | 42 | 74% |
The role of imaging in the management of progressive glioblastoma | 2014 | 6 | 80 | 49% |
Treatment-Related Change Versus Tumor Recurrence in High-Grade Gliomas: A Diagnostic Conundrum-Use of Dynamic Susceptibility Contrast-Enhanced (DSC) Perfusion MRI | 2012 | 25 | 45 | 64% |
Advanced MRI and PET imaging for assessment of treatment response in patients with gliomas | 2010 | 86 | 94 | 51% |
Role of magnetic resonance spectroscopy for the differentiation of recurrent glioma from radiation necrosis: A systematic review and meta-analysis | 2014 | 3 | 25 | 68% |
Response Assessment Criteria for Glioblastoma: Practical Adaptation and Implementation in Clinical Trials of Antiangiogenic Therapy | 2013 | 22 | 47 | 40% |
Discriminating radiation necrosis from tumor progression in gliomas: a systematic review what is the best imaging modality? | 2013 | 13 | 50 | 60% |
Differentiating tumor recurrence from treatment necrosis: a review of neuro-oncologic imaging strategies | 2013 | 14 | 127 | 55% |
The clinical value of proton magnetic resonance spectroscopy in adult brain tumours | 2007 | 67 | 59 | 68% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | TRANSLAT BRAIN TUMOR PROGRAM | 8 | 70% | 0.4% | 7 |
2 | UNITAT BIOQUIM BIOCIENCIES | 6 | 53% | 0.4% | 8 |
3 | CONTROLE MOTEUR MOUVEMENT | 4 | 67% | 0.2% | 4 |
4 | UCLA NEUROONCOL PROGRAM | 4 | 67% | 0.2% | 4 |
5 | MAGNET ONANCE SCI | 4 | 17% | 1.0% | 19 |
6 | IMAGING MED PHYS | 3 | 57% | 0.2% | 4 |
7 | UNITAT CIENCIAS | 3 | 100% | 0.2% | 3 |
8 | UNITAT CIENCIES | 3 | 37% | 0.4% | 7 |
9 | BIOMED INFORMAT SIGNALS SYST | 2 | 67% | 0.1% | 2 |
10 | BIOMED MR GRP | 2 | 67% | 0.1% | 2 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000170876 | C 11 METHIONINE//O 2 F 18FLUOROETHYL L TYROSINE//FET PET |
2 | 0.0000153729 | FAST PADE TRANSFORM//CHOLINE KINASE//CHOLINE KINASE INHIBITORS |
3 | 0.0000130867 | MAGNETIC RESONANCE SPECTROSCOPY//SPECTROSCOPIC IMAGING//LCMODEL |
4 | 0.0000126910 | DCE MRI//PHARMACEUT MOL IMAGING//DYNAMIC CONTRAST ENHANCED MRI |
5 | 0.0000117745 | EGFRVIII//RECURRENT GLIOBLASTOMA//TUMOR TREATING FIELDS |
6 | 0.0000106157 | TEMOZOLOMIDE//GLIOBLASTOMA MULTIFORME//ANAPLASTIC ASTROCYTOMA |
7 | 0.0000103352 | GLIOMATOSIS CEREBRI//GLIOMATOSIS//CEREBRAL GLIOMATOSIS |
8 | 0.0000102744 | INTRAVOXEL INCOHERENT MOTION//DIFFUSION WEIGHTED IMAGING//APPARENT DIFFUSION COEFFICIENT |
9 | 0.0000084607 | PERFUSION DIFFUSION MISMATCH//DYNAMIC SUSCEPTIBILITY CONTRAST//PENUMBRA |
10 | 0.0000081847 | DIFFUSE INTRINSIC PONTINE GLIOMA//BRAINSTEM GLIOMA//PONTINE GLIOMA |